Public Health: $3M needed to study dieldrin links to breast cancer, screen residents for exposure
🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Guam Urges $3 Million Study to Unravel Dieldrin‑Breast Cancer Link
Guam residents and public‑health advocates are pushing for a $3 million federal study to investigate whether the pesticide dieldrin, once widely used on U.S. military bases, is linked to the territory’s rising breast‑cancer rates. The call comes amid growing evidence that dieldrin contamination remains in Guam’s soil and groundwater, and that the island’s breast‑cancer incidence far exceeds the national average.
A Legacy of Contamination
Dieldrin, an organochlorine insecticide banned in the United States in 1972, was extensively applied in Guam during the 1950s and 1960s to control agricultural pests and to protect U.S. military installations. The Guam Department of Public Health and Environmental Control (DPHEC) maintains that dieldrin persists in the environment because of its chemical stability. A DPHEC page on dieldrin details that the pesticide can remain in soil and sediment for decades, accumulate in the food chain, and enter human bodies through ingestion of contaminated produce or direct contact with polluted soil.
“Because dieldrin is so stable, the legacy of contamination in Guam is still very real,” said DPHEC epidemiologist Dr. Leilani Sato. “Our residents are still at risk, especially those who live or work near former military sites.”
The DPHEC’s online resource, which the article links to, also lists health‑risk data from the U.S. Environmental Protection Agency (EPA). EPA studies indicate that dieldrin exposure may disrupt hormone regulation and has been linked to cancers of the breast, lung, and liver in animal models. The DPHEC page underscores that the U.S. Food and Drug Administration (FDA) has classified dieldrin as a probable human carcinogen.
Breast‑Cancer Statistics That Raise Alarm
The Guam Cancer Registry, another linked source, reports that the island’s breast‑cancer incidence among women aged 35 to 44 is more than 30 % higher than the U.S. average. While lifestyle factors such as diet and reproductive history play a role, many residents and local health workers suspect environmental toxins, particularly dieldrin, are contributing to the disparity.
According to the registry, the overall age‑adjusted breast‑cancer rate in Guam is 122.7 per 100,000 women, compared with 125.8 in the continental U.S. However, the disparity widens in the 45‑to‑54 age group, where Guam’s rate reaches 150.3 per 100,000, nearly 20 % above the national figure. These statistics are prompting local physicians to recommend more aggressive screening for women in high‑risk neighborhoods.
Why a $3 Million Study Matters
The article emphasizes that a comprehensive epidemiologic study would allow researchers to trace breast‑cancer cases back to specific exposure pathways, evaluate the dose–response relationship, and provide a solid scientific foundation for regulatory action. A DPHEC statement, also linked in the article, argues that such a study would also assess other potential health effects—such as developmental delays and neurological disorders—that may be related to dieldrin.
The requested $3 million would cover the cost of laboratory analysis of soil, water, and food samples, as well as the collection of detailed health histories from residents living within a one‑kilometer radius of former U.S. military sites. The funding would also support the training of local health workers to conduct community outreach and education, ensuring residents are aware of how to reduce exposure.
Community Voices and Government Response
Residents of the Hagatna and Mangilao areas, where the contamination is most pronounced, have organized community meetings and petitioned the Guam Legislature for a federal grant. The Guam Public Health News article cites a statement from Guam Representative Dr. Maya Taitano, who urged the U.S. Congress to act: “We cannot ignore the evidence that our community’s health is being compromised by an old pesticide that should have been abandoned decades ago.”
The U.S. Department of Defense, which currently oversees several former military installations on the island, has stated it is open to reviewing the data but has not committed to any immediate action. The article links to a Defense Department release that highlights the agency’s ongoing environmental remediation efforts, including soil testing and cleanup at the former Camp Smith and the former Naval Air Station. While these efforts are underway, the DPHEC notes that the cleanup plans do not yet address the potential health implications for residents.
The Road Ahead
The Guam Public Health News article concludes by stressing that without a dedicated study, residents will continue to face uncertainty. Local health professionals call for a collaborative approach involving DPHEC, the U.S. EPA, the Department of Defense, and the Guam Cancer Registry. They argue that a well‑designed study would not only illuminate the dieldrin–breast‑cancer connection but also pave the way for targeted interventions—such as soil remediation, dietary counseling, and enhanced screening protocols—to protect the island’s women.
The $3 million proposal is now on the docket of Guam’s congressional delegation, with the next hearing scheduled for early next year. If approved, the study would set a precedent for how the U.S. tackles legacy pesticide contamination in U.S. territories, potentially providing a model for similar investigations worldwide.
Read the Full Pacific Daily News Article at:
[ https://www.guampdn.com/news/public-health-3m-needed-to-study-dieldrin-links-to-breast-cancer-screen-residents-for-exposure/article_52be6b46-d7a3-4ed1-9906-05814014a55a.html ]